136 related articles for article (PubMed ID: 9503530)
61. [Xanthomatosis in patients with hyperlipoproteinemia].
Kusić M; Stanković K; Gavrilović M
Zb Vojnomed Akad; 1982; 24():14-8. PubMed ID: 6964904
[TBL] [Abstract][Full Text] [Related]
62. [Correlative role of genetic and environmental factors in the cholesterol variability of high-density lipoproteins and their subclasses].
Chepurnenko NV; Polesskiĭ VA; Koshechkin VA; Gerasimova EN
Kardiologiia; 1980 Nov; 20(11):79-83. PubMed ID: 7192330
[TBL] [Abstract][Full Text] [Related]
63. [Genealogy and the clinical manifestations of familial hyperlipidemias types IIa and IIb].
Lipovetskiĭ BM
Ter Arkh; 1993; 65(12):34-8. PubMed ID: 8146768
[TBL] [Abstract][Full Text] [Related]
64. [The role of investigating the fractional composition of high-density cholesterol lipoproteins and dys-alpha-lipoproteinemia for detection of atherogenic disorders].
Kamyshnikov VS
Klin Lab Diagn; 1994; (3):19-22. PubMed ID: 7921807
[TBL] [Abstract][Full Text] [Related]
65. [Immune and metabolic effect of polyunsaturated fatty acids omega 3 in anti-atherosclerotic diet in the treatment of patients with ischemic heart disease, familial hyperlipoproteinemia and hypertension].
Pogozheva AV; Sergeeva KV; Trushina EN; Volgarev MN; Samsonov MA
Vopr Pitan; 1994; (5):33-6. PubMed ID: 7871774
[TBL] [Abstract][Full Text] [Related]
66. Dietary control of hyperlipoproteinemia.
Lacatîs D; Bălan M; Creţeanu G
Med Interne; 1980; 18(1):49-53. PubMed ID: 7375800
[TBL] [Abstract][Full Text] [Related]
67. [Functional status of thrombocytes and the anti-aggregative activity of the vascular wall in dyslipoproteinemias and ischemic heart disease].
Mikhailova IA; Lipovetskiĭ BM; Magracheva EIa; Gurevich VS
Ter Arkh; 1989; 61(2):101-4. PubMed ID: 2727909
[TBL] [Abstract][Full Text] [Related]
68. Altered platelet deformability in patients with type IIa and type IV hyperlipoproteinemia.
Smith CM; Burris SM; Hunninghake DB; White JG
Am J Hematol; 1988 Apr; 27(4):247-52. PubMed ID: 3354559
[TBL] [Abstract][Full Text] [Related]
69. [Beta 2 glycoprotein I analysis in patients with hyperlipoproteinemia, arteriosclerotic occlusive disease and diabetes mellitus].
Müller G; Biering A; Lux E; Richter V
Z Gesamte Inn Med; 1983 May; 38(10):282-4. PubMed ID: 6613192
[TBL] [Abstract][Full Text] [Related]
70. Apolipoprotein E allele frequencies in non-insulin-dependent diabetes mellitus with hypertriglyceridemia (type IIb, III, IV, and V hyperlipoproteinemia).
Eto M; Watanabe K; Makino I; Ishii K
Metabolism; 1991 Aug; 40(8):776-80. PubMed ID: 1861626
[TBL] [Abstract][Full Text] [Related]
71. [Changes in phospholipid composition of high density lipoproteins in children as a possible precursor of the development of ischemic heart disease].
Gerasimova EN; Ozerova IN; Aingorn ED; Sipiagina AE; Belokon' NA
Kardiologiia; 1988 Sep; 28(9):61-6. PubMed ID: 3236648
[TBL] [Abstract][Full Text] [Related]
72. [Lipoprotein lipase activity of ischemic heart disease patients with different types of hyperlipoproteinemia on the basis of fat loading].
Nikul'cheva NG; Soliternova IB; Krivoruchenko IV
Vopr Med Khim; 1980; 26(6):808-13. PubMed ID: 7456412
[TBL] [Abstract][Full Text] [Related]
73. The effect of coffee deprived of irritant substances upon some indices of lipid metabolism in healthy volunteers and patients with hyperlipoproteinemia.
Hryniewiecki L; Hasik J; Grzymisławski M; Dobrowolska-Zachwieja A; Smolińska K; Adam W
Mater Med Pol; 1992; 24(3):151-2. PubMed ID: 1307641
[TBL] [Abstract][Full Text] [Related]
74. Plasma cholesterol esterification rate in hyperlipoproteinaemia: relation to cholesterol elimination.
Angelin B; Einarsson K; Leijd B; Wallentin L
Scand J Clin Lab Invest; 1988 Sep; 48(5):481-7. PubMed ID: 3206195
[TBL] [Abstract][Full Text] [Related]
75. [Changes in the active body-mass ratio (fatty mass) in hyperlipoproteinemias as affected by a combined dietetic regimen].
Naumova R; Khandzhiev S
Vutr Boles; 1982; 21(4):80-3. PubMed ID: 7147923
[TBL] [Abstract][Full Text] [Related]
76. [Features of distribution of free and esterified cholesterol in the epidermis, biological membranes and plasma lipoproteins in psoriasis].
Fortinskaia ES; Torkhovskaia TI; Sharapova GIa; Loginova TK; Kliuchnikova ZhI; Khalilov EM
Klin Lab Diagn; 1996; (4):38-43. PubMed ID: 8963558
[TBL] [Abstract][Full Text] [Related]
77. Alfalfa seeds lower low density lipoprotein cholesterol and apolipoprotein B concentrations in patients with type II hyperlipoproteinemia.
Mölgaard J; von Schenck H; Olsson AG
Atherosclerosis; 1987 May; 65(1-2):173-9. PubMed ID: 3606731
[TBL] [Abstract][Full Text] [Related]
78. [Serum apolipoprotein E levels in 238 healthy adults and 161 hyperlipidemic subjects in Chengdu area].
Liu M; Liu B
Hua Xi Yi Ke Da Xue Xue Bao; 1992 Sep; 23(3):261-3. PubMed ID: 1298713
[TBL] [Abstract][Full Text] [Related]
79. Sarcoidosis and acquired type II-b hyperlipoproteinaemia.
Umeki S; Niki Y; Soejima R
Eur Respir J; 1988 Jun; 1(6):558-9. PubMed ID: 3169225
[TBL] [Abstract][Full Text] [Related]
80. [Plasma levels of testosterone and lipid-protein components of high density lipoproteins and their subclasses in the native population of the Chukotka national autonomic region].
Chepurnenko NV; Gerasimova EN; Polesskiĭ VA; Metel'skaia VA; Koshechkin VA
Kardiologiia; 1983 Mar; 23(3):42-6. PubMed ID: 6855060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
